HOME >> MEDICINE >> NEWS
Ruling out pulmonary embolism with a simple bedside protocol

Although clots in the lung (pulmonary embolism or PE) are the second-leading cause of sudden death in the United States, blood tests and ultrafast CT scanning to detect PE are being used on so many patients that over 90% of these tests are negative. In a paper to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, Jeff Kline, MD, Carolinas Medical Center, Charlotte, NC, will show that the use of simple clinical criteria can eliminate the risk and expense of these unnecessary tests.

The Pulmonary Embolism Rule-out Criteria, or the PERC rule, functions as a way to rule out clots in the lung. The blood test, called D-Dimer, has a very low specificity for PE, leading to many false positives. The CT scan costs $2500, has the potential for kidney damage in 1 in 12 patients, and has a heavy radiation dose that increases lifetime risk of cancer. Yet, doctors are ordering these tests for 2-3% of all Emergency Department patients or 3.5 million cases per year. According to the author, the fear of medical malpractice has led to a culture of doing tests rather than using the data available through clinical evaluation.

The study looked at an 8,138 patient random sample from 13 hospitals. By using a Web-based real-time data collection method and an extremely rigorous study design, it was able to capture the doctors beliefs at the time of treatment, prior to the time that results were available. Importantly, the study design captured the physicians "gestalt" or gut instinct of how likely they thought PE was on their list. The results showed that fully two thirds of all testing is done in patients where the physician believed that the probability of PE was less than 15%.

In the best case, this study could reduce testing for PE by approximately 20-25%. More importantly, this is a first step toward a culture change of using intelligent clinical criteria instead of expensive technology to rule out life-threatening d
'"/>

Contact: Linda Gruner
l.gruner@elsevier.com
212-633-3923
Elsevier Health Sciences
16-May-2007


Page: 1 2

Related medicine news :

1. Sildenafil prevents rebound pulmonary hypertension in infants
2. A simple, noninvasive test measures survival time in adult pulmonary hypertension
3. Exercise improves quality of life for patients with severe chronic pulmonary hypertension
4. New guidelines help clinicians assess risk of post-surgical pulmonary complications
5. Hormone can predict pulmonary hypertension and potential death or survival
6. Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
7. New model may help identify patients with pulmonary embolism who are at low risk of death
8. Exercise improves cardiopulmonary fitness in asthma
9. CHEST 2005 hosts world experts in pulmonary, sleep, and critical care medicine
10. Use of pulmonary artery catheterization does not show benefit for severe heart failure patients
11. Sildenafil (Viagra) approved for treatment of pulmonary arterial hypertension (PAH) as Revatio

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ruling out pulmonary embolism with simple bedside protocol

(Date:5/19/2013)... IL (PRWEB) May 19, 2013 In partnership ... LLC, E-dentist.com has announced the launch of an SEO website ... dentists get high rankings in Google. , http://www.e-dentists.com/ ... not pay for the service until they see results. Dentists ... The lead generation websites run by JD Media Surge, LLC ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Grinding your ... just losing sleep, or annoying your spouse. At the ... by CNY Central (“Snoring and Teeth Grinding Could Be ... of teeth grinding can be hard to prevent. Apparently, ... Americans, and one of its symptoms is a habit ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock ... 2017” published by MarketsandMarkets, defines and segments the global ... the global volume and revenue for the animal feed ... for the global market with analysis of trends, opportunities, ... segmented and revenue is forecasted on the basis of ...
(Date:5/19/2013)... May 19, 2013 Farming methods have ... in the ground 10,000 years ago. Most recently, the ... productivity by using genetically engineered seeds and by applying ... a backlash to these techniques due to the adverse ... and a corresponding surge in interest in organic, sustainable ...
(Date:5/19/2013)... Yeast infections are common in both men and women. ... human body. A new yeast infection treatment product has been ... method of application to help eliminate over growth of the ... men and women searching for a natural process of yeast ... food and is stored in the intestines. In small consumable ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2
(Date:5/16/2013)... N.C. , May 16, 2013  Today, the ... North Carolina House of Representatives recently approved ... for chemotherapy from charging patients higher out-of-pocket fees for ... formularies, many of which have more severe side-effects. However, ... limit of $300, which will continue to be a ...
(Date:5/16/2013)... -- Alere Inc. (NYSE: ALR ), a global leader ... home through the merger of rapid diagnostics and health management, ... its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The ... record of Series B stock at the close of business ... the amount of all dividends accrued from April 1, 2013 ...
(Date:5/16/2013)... Calif. , May 16, 2013 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies for ... Richard King , President and CEO, will ... at the Sheraton New York Hotel in New ... May 22, 2013 at 9:30 a.m. ET/6:30 a.m. PT. ...
Breaking Medicine Technology:National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3
Cached News: